Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma. (2014)

First Author: Delord JP
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2013.10.015

PubMed Identifier: 24262587

Publication URI: http://europepmc.org/abstract/MED/24262587

Type: Journal Article/Review

Volume: 50

Parent Publication: European journal of cancer (Oxford, England : 1990)

Issue: 3

ISSN: 0959-8049